Literature DB >> 15953579

Disease course of patients with pericentral retinitis pigmentosa.

Michael A Sandberg1, Alexander R Gaudio, Eliot L Berson.   

Abstract

PURPOSE: To estimate the mean rates of decline of ocular function in patients with an atypical form of retinitis pigmentosa, termed "pericentral retinitis pigmentosa."
DESIGN: Retrospective observational study.
METHODS: setting: Single-center. patient population: Eighteen patients (ages 32 to 65 years) with pericentral retinitis pigmentosa followed for 3 to 26 years. observational procedures: Snellen visual acuity, Goldmann visual field area (V-4e white test light), and full-field electroretinogram (ERG) amplitudes (0.5 Hz and 30 Hz white flashes). main outcome measures: Mean annual exponential rates of change quantified by repeated-measures longitudinal regression.
RESULTS: Estimated mean annual rates of decline of remaining ocular function were 1.2% for visual acuity, 1.9% for visual field area, 2.5% for ERG amplitude to 0.5 Hz flashes, and 2.9% for ERG amplitude to 30 Hz flashes.
CONCLUSIONS: The mean rates of loss of remaining ocular function of patients with pericentral retinitis pigmentosa were generally slower than those previously reported for patients with typical forms of retinitis pigmentosa.

Entities:  

Mesh:

Year:  2005        PMID: 15953579     DOI: 10.1016/j.ajo.2005.02.038

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  15 in total

1.  Disease course of patients with unilateral pigmentary retinopathy.

Authors:  Emorfily Potsidis; Eliot L Berson; Michael A Sandberg
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-29       Impact factor: 4.799

2.  Molecular Heterogeneity Within the Clinical Diagnosis of Pericentral Retinal Degeneration.

Authors:  Rodrigo Matsui; Artur V Cideciyan; Sharon B Schwartz; Alexander Sumaroka; Alejandro J Roman; Malgorzata Swider; Wei Chieh Huang; Rebecca Sheplock; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-09       Impact factor: 4.799

3.  Visual Function in Carriers of X-Linked Retinitis Pigmentosa.

Authors:  Jason Comander; Carol Weigel-DiFranco; Michael A Sandberg; Eliot L Berson
Journal:  Ophthalmology       Date:  2015-07-02       Impact factor: 12.079

4.  IFT88 mutations identified in individuals with non-syndromic recessive retinal degeneration result in abnormal ciliogenesis.

Authors:  Anil Chekuri; Aditya A Guru; Pooja Biswas; Kari Branham; Shyamanga Borooah; Angel Soto-Hermida; Michael Hicks; Naheed W Khan; Hiroko Matsui; Akhila Alapati; Pongali B Raghavendra; Susanne Roosing; Sripriya Sarangapani; Sinnakaruppan Mathavan; Amalio Telenti; John R Heckenlively; S Amer Riazuddin; Kelly A Frazer; Paul A Sieving; Radha Ayyagari
Journal:  Hum Genet       Date:  2018-07-05       Impact factor: 4.132

5.  ERG and other discriminators between advanced hydroxychloroquine retinopathy and retinitis pigmentosa.

Authors:  Archana A Nair; Michael F Marmor
Journal:  Doc Ophthalmol       Date:  2017-04-27       Impact factor: 2.379

6.  Intravitreal pegaptanib sodium (Macugen) for refractory cystoid macular edema in pericentral retinitis pigmentosa.

Authors:  Giuseppe Querques; Francesco Prascina; Cristiana Iaculli; Nicola Delle Noci
Journal:  Int Ophthalmol       Date:  2007-12-22       Impact factor: 2.031

7.  Long-term visual prognoses in patients with retinitis pigmentosa: the Ludwig von Sallmann lecture.

Authors:  Eliot L Berson
Journal:  Exp Eye Res       Date:  2007-03-07       Impact factor: 3.467

Review 8.  Retinitis pigmentosa.

Authors:  Christian Hamel
Journal:  Orphanet J Rare Dis       Date:  2006-10-11       Impact factor: 4.123

9.  Pigmented paravenous retinochoroidal atrophy (Review).

Authors:  Hou-Bin Huang; Yi-Xin Zhang
Journal:  Exp Ther Med       Date:  2014-03-28       Impact factor: 2.447

10.  The Genetic Basis of Pericentral Retinitis Pigmentosa-A Form of Mild Retinitis Pigmentosa.

Authors:  Jason Comander; Carol Weigel-DiFranco; Matthew Maher; Emily Place; Aliete Wan; Shyana Harper; Michael A Sandberg; Daniel Navarro-Gomez; Eric A Pierce
Journal:  Genes (Basel)       Date:  2017-10-05       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.